Search Results - "Moreau, Huberte"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Inhibition of Vascular Endothelial Growth Factor Reduces Scar Formation after Glaucoma Filtration Surgery by Li, Zhongqiu, Van Bergen, Tine, Van de Veire, Sara, Van de Vel, Isabelle, Moreau, Huberte, Dewerchin, Mieke, Maudgal, Prabhat C, Zeyen, Thierry, Spileers, Werner, Moons, Lieve, Stalmans, Ingeborg

    “…Filtration failure due to excessive postoperative scarring remains a major problem after glaucoma surgery. The authors have investigated whether glaucoma and…”
    Get full text
    Journal Article
  2. 2

    Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction by COLLEN, Désiré, SINNAEVE, Peter, DEMARSIN, Eddy, MOREAU, Huberte, DE MAEYER, Marc, JESPERS, Laurent, LAROCHE, Yves, DE WERF, Frans Van

    Published in Circulation (New York, N.Y.) (10-10-2000)
    “…Thrombolytic therapy of acute myocardial infarction (AMI) is evolving toward bolus administration. Derivatization of proteins with polyethylene glycol (PEG)…”
    Get full text
    Journal Article
  3. 3

    Recombinant staphylokinase variants with altered immunoreactivity. II: Thrombolytic properties and antibody induction by COLLEN, D, MOREAU, H, STOCKX, L, VANDERSCHUEREN, S

    Published in Circulation (New York, N.Y.) (15-07-1996)
    “…The substitution variants K35A,E38A,K74A, E75A,R77A (SakSTAR.M38) and K74A,E75A,R77A,E80A, D82A (SakSTAR.M89) of recombinant staphylokinase (SakSTAR) with…”
    Get full text
    Journal Article
  4. 4

    Predictive value of increased plasma levels of fibronectin in gestational hypertension by Ballegeer, V, Spitz, B, Kieckens, L, Moreau, H, Van Assche, A, Collen, D

    “…Blood pressure, proteinuria, and plasma fibronectin and plasminogen activator inhibitor-1 levels were measured in 120 apparently healthy normotensive…”
    Get more information
    Journal Article
  5. 5

    Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator by Bartha, K, Declerck, P J, Moreau, H, Nelles, L, Collen, D

    Published in The Journal of biological chemistry (15-01-1991)
    “…The effects of recombinant tissue-type plasminogen activator (rt-PA) and of an inactive mutant of rt-PA, obtained by mutagenesis of the active site Ser478 to…”
    Get full text
    Journal Article